Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:1713-1714
Published online before print April 12, 2007, doi: 10.1161/STROKEAHA.107.487223
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/6/1713    most recent
STROKEAHA.107.487223v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chaturvedi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chaturvedi, S.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Attack
*Stroke
Related Collections
Right arrow Lipids
Right arrow Cerebrovascular disease/stroke
Right arrow Chronic ischemic heart disease
Right arrow Epidemiology
Right arrowRelated Article

(Stroke. 2007;38:1713.)
© 2007 American Heart Association, Inc.


Editorials

Should Stroke Be Considered Both a Brain Attack and a Heart Attack?

Seemant Chaturvedi, MD, FAHA, FAAN

From the Department of Neurology and Stroke Program, Wayne State University, Detroit, Mich.

Correspondence to Seemant Chaturvedi, MD, Department of Neurology & Stroke Program, Wayne State University, 8C-UHC, 4201 St. Antoine, Detroit, MI 48201. E-mail SChaturv@med.wayne.edu


Key Words: cardiac disease • statins


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

See related article, pages 1752–1758.

The concept of coronary risk equivalents has gained increased acceptance in recent years. In the 2001 National Cholesterol Education Program (NCEP) Adult Treatment Panel III guidelines, diabetes mellitus, peripheral arterial disease, abdominal aortic aneurysm, and "symptomatic carotid artery disease" were cited as coronary risk equivalents.1 These conditions carry a 10-year risk of coronary heart disease events of >20%.

In 2004, the tent containing coronary risk equivalent conditions was expanded by the NCEP committee to symptomatic carotid disease or ">50% obstruction of a carotid artery."2 In addition, whereas in 2001, the low-density lipoprotein target for coronary risk equivalents was <100 mg/dL, in 2004, an optional target of <70 mg/dL was established for high-risk patients.

In this issue of Stroke, Dhamoon et al, using data from the Northern Manhattan Study, provide further ammunition to support the enlargement of the coronary risk equivalent umbrella.3 These authors followed 655 patients (aged 40 years or older) with a first ischemic stroke for a 5-year period. In their overall population, the 5-year risk of myocardial infarction (MI) or vascular death (VD) was 17.4%. There was an increased "up front" risk of 8.2% at one year. Their study also identified age >70 years, history of coronary artery disease, and atrial fibrillation as independent predictors of MI or VD. Embolic stroke subtype was particularly ominous, whereas lacunar stroke subtype was less risky. The 5-year risk of MI or VD was 11.5% in patients aged 70 years and over with lacunar infarcts, . . . [Full Text of this Article]


Related Article:

Risk of Myocardial Infarction or Vascular Death After First Ischemic Stroke: The Northern Manhattan Study
Mandip S. Dhamoon, Wanling Tai, Bernadette Boden-Albala, Tanja Rundek, Myunghee C. Paik, Ralph L. Sacco, and Mitchell S.V. Elkind
Stroke 2007 38: 1752-1758. [Abstract] [Full Text] [PDF]